Cargando…
Longitudinal evaluation of serum microRNAs as biomarkers for neuroblastoma burden and therapeutic p53 reactivation
Accurate assessment of treatment response and residual disease is indispensable for the evaluation of cancer treatment efficacy. However, performing tissue biopsies for longitudinal follow-up poses a major challenge in the management of solid tumours like neuroblastoma. In the present study, we eval...
Autores principales: | Van Goethem, Alan, Deleu, Jill, Yigit, Nurten, Everaert, Celine, Moreno-Smith, Myrthala, Vasudevan, Sanjeev A, Zeka, Fjoralba, Demuynck, Fleur, Barbieri, Eveline, Speleman, Frank, Mestdagh, Pieter, Shohet, Jason, Vandesompele, Jo, Van Maerken, Tom |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9846426/ https://www.ncbi.nlm.nih.gov/pubmed/36683916 http://dx.doi.org/10.1093/narcan/zcad002 |
Ejemplares similares
-
Dual targeting of MDM2 and BCL2 as a therapeutic strategy in neuroblastoma
por: Van Goethem, Alan, et al.
Publicado: (2017) -
Depletion of tRNA-halves enables effective small RNA sequencing of low-input murine serum samples
por: Van Goethem, Alan, et al.
Publicado: (2016) -
Ribosomal RNA 2′O-methylation as a novel layer of inter-tumour heterogeneity in breast cancer
por: Marcel, Virginie, et al.
Publicado: (2020) -
Characterizing and classifying neuroendocrine neoplasms through microRNA sequencing and data mining
por: Nanayakkara, Jina, et al.
Publicado: (2020) -
Hypoxia-induced TGF-β–RBFOX2–ESRP1 axis regulates human MENA alternative splicing and promotes EMT in breast cancer
por: Ahuja, Neha, et al.
Publicado: (2020)